Levetiracetam Tablets USP — Class III drug recall D-0630-2021
Terminated recall by McKesson Corporation dba McKesson Drug Company, reported 2021-06-16, distributed nationwide. Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as
| Recall number | D-0630-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | McKesson Corporation dba McKesson Drug Company, Memphis, TN, United States |
| Recall initiated | 2021-05-26 |
| Classified | 2021-06-15 |
| Reported by FDA | 2021-06-16 |
| Terminated | 2022-09-29 |
| Distributed | Nationwide (US) |
| Quantity | 210 cartons |
| Reason classes | labeling |
| NDC | 63739-0795-10 |
| Lot numbers | 0000124916 |
| Expiration dates | 2022-09-30 |
Product
Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10
Reason for recall
Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0630-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.